7:30AM NuPathe appoints Armando Anido as Chief Executive Officer effective immediately (PATH) 3.62 : Co announced the appointment of Armando Anido as chief executive officer, effective immediately. He succeeds Jane Hollingsworth, who has resigned as chief executive officer and as a member of the Company's board of directors. Mr. Anido has also been appointed to the Company's board of directors. Mr. Anido is currently a member of the board of directors of Respira Therapeutics and was a member of the board of directors of Adolor until it was sold to Cubist (CBST) in December 2011. He is the former president and CEO of Auxilium Pharmaceuticals (AUXL).
Market Data 
Markets 
AI
